Incorporating utility-based quality-of-life assessment measures in clinical trials
| dc.contributor.author | Feeny, David | en_US |
| dc.contributor.author | Torrance, George W. | en_US |
| dc.contributor.author | Centre for Health Economics and Policy Analysis | en_US |
| dc.date.accessioned | 2015-04-14T14:42:01Z | |
| dc.date.available | 2015-04-14T14:42:01Z | |
| dc.date.issued | 1989 | en_US |
| dc.description | David Feeny, George W. Torrance. | en_US |
| dc.description | Bibliography: leaves 22-25. | en_US |
| dc.format.extent | 25 leaves. | en_US |
| dc.identifier.uri | http://hdl.handle.net/11375/17082 | |
| dc.publisher | Centre for Health Economics and Policy Analysis] | en_US |
| dc.relation.ispartofseries | CHEPA working paper series no. 12 | en_US |
| dc.subject | Economics, Medical | en_US |
| dc.subject | Value of Life | en_US |
| dc.subject | Quality of Life | en_US |
| dc.subject | Physicians | en_US |
| dc.subject | supply & distribution | en_US |
| dc.subject | Clinical Trials as Topic | en_US |
| dc.subject | methods | en_US |
| dc.subject | Outcome and Process Assessment (Health Care) | en_US |
| dc.subject | methods | en_US |
| dc.title | Incorporating utility-based quality-of-life assessment measures in clinical trials | en_US |
| dc.type | text | en_US |